ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 367 out of 1904

$527K Total Retail Price of All Prescriptions

Rank: 451 out of 1904

443 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Indiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 394 361 83 1 4
LEVOTHYROXINE SODIUM 346 329 73 2 1
LISINOPRIL 271 248 58 3 3
AMLODIPINE BESYLATE 246 241* 57 4 6
METFORMIN HCL 207 202* 42 5 9
CITALOPRAM HBR 197 192* 34 6 22
POLYETHYLENE GLYCOL 3350 192 187* 35 7 50
OMEPRAZOLE 191 167 40 8 5
FUROSEMIDE 182 177* 47 9 7
HYDROCODONE-ACETAMINOPHEN 168 125 46 S3 10 2
WARFARIN SODIUM 160 146 28 11 14
TRAMADOL HCL 159 131 46 12 18
HYDROCHLOROTHIAZIDE 152 147* 38 13 11
METOPROLOL TARTRATE 138 133* 32 14 12
RANITIDINE HCL 137 117 18 15 43
QUETIAPINE FUMARATE 134 109 17 A 16 77
TAMSULOSIN HCL 133 128* 33 17 26
ATORVASTATIN CALCIUM 129 124* 35 18 8
NAMENDA 126 <11 <11 19 28
SERTRALINE HCL 119 91 17 20 25
POTASSIUM CHLORIDE 112 107* 26 21 17
METOPROLOL SUCCINATE 106 94 19 22 16
ADVAIR DISKUS 103 103 17 23 56
DONEPEZIL HCL 97 97 15 24 32
ATENOLOL-CHLORTHALIDONE 96 91* 27 25 162
ATENOLOL 94 94 26 26 19
GABAPENTIN 94 89* 24 26 13
CLOPIDOGREL 83 83 16 28 20
PREDNISONE 83 78* 42 28 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 76* 25 30 23
GLIPIZIDE 81 76* 16 30 73
MIRTAZAPINE 77 72* 11 32 57
CARBIDOPA-LEVODOPA 74 <11 <11 33 113
ALLOPURINOL 73 68* 18 34 31
ZOLPIDEM TARTRATE 73 42 17 34 30
KLOR-CON M20 73 73 12 34 59
KLOR-CON M10 72 <11 <11 37 145
ISOSORBIDE MONONITRATE ER 67 62* 11 38 64
MELOXICAM 66 61* 18 39 29
DIGOX 60 60 11 40 126
FENTANYL 59 <11 <11 S2 41 74
CLONIDINE HCL 59 <11 <11 41 66
NITROFURANTOIN MONO-MACRO 58 58 15 43 153
ALPRAZOLAM 58 32 15 B 43 15
OXYBUTYNIN CHLORIDE 58 58 11 43 95
OXYBUTYNIN CHLORIDE ER 56 <11 <11 46 129
EXELON 54 <11 <11 47 123
VESICARE 52 <11 <11 48 149
CEPHALEXIN 51 51 15 49 58
LEVEMIR 50 <11 <11 50 142
MONTELUKAST SODIUM 50 <11 <11 50 53
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.